UnitedHealth CEO remembers slain colleague, talks about root cause of health care woes
UnitedHealth Group CEO Andrew Witty acknowledged the U.S. health care problems, cited high prices of medical services as root ...
Hosted on MSN2d
Brian Thompson's boss: Pharma companies are "really responsible" for drug prices
The CEO of the company whose insurance leader was killed in New York pledged to help fix the health care industry while also ...
Modern Healthcare3d
UnitedHealth to report first earnings since exec’s murder
UnitedHealth Group’s upcoming earnings call marks the company's first public appearance since the murder of UnitedHealthcare ...
UnitedHealth Group CEO: US health care needs to be ‘less confusing, less complex and less costly’
In its first results since its insurance unit CEO was fatally shot in New York City, UnitedHealth Group reported Thursday ...
UnitedHealth tops profit forecasts but medical costs linger for health care giant
UnitedHealth posted a better-than-expected fourth-quarter profit, but a nagging rise in medical costs and care utilization ...
UnitedHealth Group CEO says complex US healthcare system needs to change
UnitedHealth reported fourth-quarter results on Thursday that reflected persistent challenges for the health insurance sector ...
UnitedHealth Group CEO: U.S. Health System Needs To Function Better
In his first public comments since one of his executives was shot to death, UnitedHealth Group CEO Andrew Witty said the ...
Amid scrutiny of insurance costs, UnitedHealth Group reports $5.5B quarterly profits
UnitedHealth Group has reported quarterly profits of $5.5 billion after tax in its first earnings release since the killing ...
UnitedHealth to Report First Earnings Since Executive’s Murder
UnitedHealth Group Inc. is set to report financial results Thursday, the first time its executives will speak publicly since ...
UnitedHealth, employer of slain exec Brian Thompson, found to have overcharged some cancer patients for drugs by over 1,000%
CVS Caremark Rx blasted the findings for cherry picking certain drugs in an effort to push what it called an 'anti-PBM' ...